Attended an enriching 3D Echocardiography Workshop and excellent academic discussions with @DrHaniMahmoud at #SHS2026. A valuable step towards enhancing cardiac imaging expertise. #3DEcho #Cardiology #Echofirst

📄 Is LV diameter enough in mitral regurgitation… or are we missing the full picture? 🔗 doi.org/10.1093/ehjimp/qyag0… 🫀 In patients with significant mitral regurgitation (MR), 👉 timing of intervention depends heavily on LV remodelling But here’s the problem: ❌ LV end-systolic diameter (LVESD) is simple… ❗ but often inconsistent and incomplete ✨ This study asks a key question: 👉 Can 3D LV end-systolic volume (3D LVESV) improve risk stratification? 🔬 Study design (3D-PRIME): 👥 227 patients with moderate or greater MR ✔ Primary MR (PMR) ✔ Secondary MR (SMR) 📅 Follow-up: ~2 years 🎯 Outcomes: ➡️ MR progression → intervention ➡️ Death ➡️ HF hospitalization 📊 Key findings: 🔥 Increased 3D LVESV = higher risk 👉 In primary MR: ✔ ~2x higher risk of adverse events 👉 In secondary MR: ✔ ~4x higher risk of death/HF hospitalization ⚠️ Discordance matters: 📉 27% of PMR patients had mismatch between: ✔ LVESD ✔ 3D LVESV 👉 And here’s the key: 💥 Patients with increased 3D LVESV (even with normal diameter) ➡️ Still had high risk 📈 The graphical abstract (page 2) highlights: ✔ 3D LVESV identifies high-risk patients missed by diameter ✔ Best risk prediction when combining both measures 🧠 Why this matters: 👉 LV remodelling is 3D, not linear ❗ Diameter = one dimension ✅ Volume = full geometry ➡️ 3D echo avoids: ✔ Geometric assumptions ✔ LV foreshortening ✔ Underestimation of true dilatation 🚀 Clinical implications: 👉 Don’t rely on LVESD alone ✔ Add 3D LVESV for: ➡️ Better risk stratification ➡️ Earlier identification of high-risk patients ➡️ Improved timing of intervention 💡 Especially in borderline or asymptomatic MR ⚠️ Take-home message: 🧩 The ventricle doesn’t remodel in 1D… so why measure it that way? 👉 3D LVESV adds critical prognostic value beyond diameter. #Cardiology #Echocardiography #MitralRegurgitation #3DEcho #CardiacImaging #HeartFailure #ValvularHeartDisease #PrecisionMedicine 🫀📊

📄 Are we misclassifying mitral regurgitation in MVP? 🔗 doi.org/10.1093/ehjimp/qyag0… 🫀 Mitral valve prolapse (MVP) is the leading cause of primary MR… 👉 but accurately quantifying MR remains a major challenge Why? ❗ Eccentric jets ❗ Multiple jets ❗ Non-holosystolic regurgitation ➡️ Traditional methods (PISA, 2D echo) often fall short ✨ This study explores a smarter approach: 👉 Three-dimensional continuity equation (3D-CE) 🔬 Study design: 👥 72 MVP patients (65% female, mean age ~60) 📊 Compared: ✔ 3D-CE ✔ Conventional diameter-based CE (2D-CE) ✔ CMR (gold standard) 📊 Key findings: ⚠️ 2D-CE overestimates MR severity ➡️ 19 mL bias vs 3D-CE 🔥 3D-CE vs CMR: ✔ Excellent agreement (r ≈ 0.93–0.94) ✔ Minimal bias ( 2.1 mL) ❌ PISA performance limited ➡️ Especially in patients with multiple jets (r = 0.40) 📈 The graphical abstract (page 2) clearly shows: ✔ Strong concordance between 3D-CE and CMR ✔ Systematic overestimation with 2D methods 🧠 Why this matters: 👉 MVP anatomy is complex: ✔ Non-circular annulus ✔ Bileaflet prolapse (86%) ✔ High prevalence of MAD (96%) ❗ Assuming a circular annulus (as in 2D methods) → major source of error 👉 3D imaging captures true anatomy ➡️ More accurate regurgitant volume 🚀 Clinical implications: 👉 In patients with moderate or borderline MR: ✔ Better classification ✔ Better timing of intervention ✔ Reduced risk of under/over-treatment 💡 Supports a multimodality approach (Echo CMR) ⚠️ Take-home message: 🧩 In MVP, geometry matters. 👉 If you measure MR with the wrong shape… you get the wrong answer. ➡️ 3D-CE brings us closer to the truth. #Cardiology #Echocardiography #MitralRegurgitation #MVP #CardiacImaging #3DEcho #CMR #ValvularHeartDisease #Innovation 🫀📊

I am delighted to be visiting Melbourne this August to present at the Advanced Echo Masterclass, hosted by the Victorian Heart Hospital and @GEHealthCare Looking forward to connecting with cardiologists, echocardiographers, and clinicians! #3decho

This Is NOT a CT Scan. It’s a 4D Echocardiographic View of a Left Atrial Myxoma #Myxoma #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

The leaflet fractured. 4D exposed it. #Mitral #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

At the #3DEcho conference at UN Mehta Institute in Ahmedabad, India @purviparwani @ASE360 @EACVIPresident @EchoSoliman

Three planes. One valve. One truth. 3D MPR FlexiSlice redefining mitral valve area assessment in rheumatic stenosis. #Mitral #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

Late Failure of Rheumatic Mitral Annuloplasty — 4D TEE Dual View #Mitral #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

Surgeons Love This View 👀 4D Barlow Anatomy #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

Inside the Mitral Valve in True 4D A2 prolapse through the surgeon’s eyes. #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

🫀#MR in #HF is far more than “mild, moderate, severe”. ⚠️Accurate MR assessment directly influences HF management & outcomes. Excellent overview by @anatimoteo46040 at #HeartFailure26 on how we should assess secondary MR in HF: 📍Mechanism matters: Ventricular vs atrial MR, differentiate early 📍MR grading must be multiparametric, Never rely on a single number alone. 📍Secondary MR is dynamic, Severity may change after: GDMT optimization, CRT, rhythm/rate control, decongestion. ⚠️Reassess before intervention decisions. 📍Multimodality imaging matters, each provide complementary information on anatomy, mechanism, ventricular remodeling, procedural suitability 📍Heart Team discussion is essential. 📍Quantitative parameters matter most when deciding advanced therapies @escardio @EACVIPresident @VictoriaDe32503 #EchoFirst #whyCMR #YesCCT #3DEcho #HeartFailure

📣 𝐄𝐂𝐇𝐎-𝐒𝐔𝐑𝐆𝐄𝐑𝐘 𝐋𝐀𝐁  𝐕𝐈𝐈 𝐄𝐝𝐢𝐭𝐢𝐨𝐧 The course where Echo and Surgery meet each other! 💡 Not only frontal lessons, but true interactive sessions and workshops with imagers, cardiac surgeons, interventionalists and anatomopathologist. 👉 TEE simulator, 3Decho workstations, Wet Lab on pig's heart and inspection of anatomic specimen. 🔥 Let's take a look to this video in order to compare 3D echo findings of rheumatic mitral stenosis and a real rheumatic valve after cardiac surgery. ✅commissures fusion ✅fish mouth opening ✅AML doming ✅thickening and retraction of subvalvular apparatus 📅 𝟐𝟐-𝟐𝟑 𝐌𝐀𝐘 𝟐𝟎𝟐𝟔 📍 𝐒𝐚𝐧𝐭𝐚 𝐌𝐚𝐫𝐢𝐚 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 - 𝐆𝐕𝐌 , 𝐁𝐚𝐫𝐢 Program: mics.mitralacademy.it/it-it/… 𝑊𝑒 𝑎𝑟𝑒 𝑟𝑒𝑎𝑑𝑦 𝑓𝑜𝑟 𝑎 𝑤𝑜𝑛𝑑𝑒𝑟𝑓𝑢𝑙 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑒𝑥𝑝𝑒𝑟𝑖𝑒𝑛𝑐𝑒

From P1 to P3: Mapping the Alfieri Stitch in 3D with Multi-Planar TEE #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

Double-Orifice Mitral Valve One Year After Alfieri: When 3D TEE Tells the Whole Story #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

#3DEcho for #LAAC The best way to guide this procedure (planning / implant / follow up). #watchmanflx @bostonsci @BostonSciLatam @BSCCardiology @SONECOM_AC @SOME_IC @ImagenCardiaca @iamritu @NMerke @MigueldeBoedo @MAecocardio @GEHealthCare @GE_IanMc @HugoMartinezCMR @ASE360

Thanks @alexsfelixecho for your excellent talk and continued support to our #Master! #3DEcho at its best 🪄 Hope to see you in person next time 🩷

“TUSI Valve: A Striking Case of Drug-Induced Mitral Disease on Advanced Imaging” #3DEcho #echocardiography #cardiology #EchoFirst #TEE @ASE360

Any Comment About The Tricuspid Valve? #EACVI #EchoFirst #3DEcho

ASE experts connect with industry partners to drive advances in the field like #Strain #3DEcho & #ArtificialIntelligence while focusing on disease diagnosis in #HCM #Amyloidosis #ValveDisease & more! bit.ly/4247EQ4 #ASEIRT #PartnersInInnovation #HeartofASE #ASEMemberDay